A STUDY OF ANTI-HYPERLIPIDEMIC ACTIVITY OF MARKETED FORMULATIONS OF TERMINALIA ARJUNA POWDER USING EXPERIMENTAL ANIMAL MODEL
Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2015, Vol 4, Issue 1
Abstract
Hyperlipidemia is a disorder of lipid metabolism which is major risk of coronary heart disease. Now a day’s synthetic drugs have been associated with number of side effects but herbal medicines have lipid lowering and antioxidant activities without any side effects. Some traditionally herbs like: - Commiphora mukul (Gugglul), Terminalia Arjuna (Arjun), Picrorrhiza Kurroa(Kutki), Allium Sativum (Lasuna), etc. are used as Antihyperlipidemic drug in ayurvedic literature. Hence the present study was undertaken to investigate the antihyperlipidemic effect of marketed formulations of terminalia arjuna against Triton WR-1339 induced hyperlipidemia in rats at 200 and 400 mg/kg dose inhibited the elevation of serum cholesterol and triglyceride levels in hyperlipidemic rats. Marketed formulations also significantly decreased 3-hydroxy-3-methylglutaryl- CoA reductase (HMG-CoA reductase) activity at the dose of 200mg/kg and 400mg/kg; p.o. showed good antihyperlipidemic activity in Triton WR-1339 induced hyperlipidemic rats. The probable mechanism of action of the marketed formulations may be inhibition of HMG-CoA reductase enzyme pathway.
Authors and Affiliations
Sharma S| Maharishi Arvind Institute of pharmacy, mansarovar, jaipur, Rajasthan, India- 302020, Asija R| Maharishi Arvind Institute of pharmacy, mansarovar, jaipur, Rajasthan, India- 302020, Kumawat R S| Maharishi Arvind Institute of pharmacy, mansarovar, jaipur, Rajasthan, India- 302020, Chaudhary P| Maharishi Arvind Institute of pharmacy, mansarovar, jaipur, Rajasthan, India- 302020, Sharma P K| Maharishi Arvind Institute of pharmacy, mansarovar, jaipur, Rajasthan, India- 302020
Keywords
Related Articles
- EP ID EP3501
- DOI -
- Views 387
- Downloads 16
In Vitro Release Kinetics Study of Indomethacin 12Hr Matrix Tablet From Methocel K4M CR and Methocel K15M CR.
The objective of the present study was to design and evaluate controlled release tablets of Indomethacin, employing release retarding materials semi synthetic polymers Methocel K4M CR and Methocel K15M CR. There were nin...
ANALYSIS OF PRIMARY METABOLITES FROM VERTICILLIUMLECANII AND STUDIED ITS IMMUNOLOGICAL ASPECTS OF CRUDE PROTEASE AGAINST RAPITHER-AB
Objective- The objective of our study is to examine its primary metabolites (protein content) from dried powder of Verticilliumlecanii. In addition, immunological studies were conducted in order to analyzing the protease...
HAEMOGLOBIN F LEVEL AND HAEMATOLOGICAL FEATURE AMONG SUDANESE CHILDREN WITH SICKLE CELL ANAEMIA UNDERGOING HYDROXYUREA THERAPY
Sickle cell anemia (SCA) is one of the major types of anemia found in Sudan.The aim of this study is to evaluate the effect of Hydroxyurea (HU) treatment on Hb F level, reticulocyte count and the haematological feature a...
FORMULATION AND EVALUATION OF IMMEDIATE RELEASE TABLETS OF FLUNARIZINE DI-HYDROCHLORIDE
Immediate release tablets have started gaining popularity and acceptance as a drug delivery system, mainly because they are easy to administer, has quick onset of action, economical and lead to better patient compliance....
Prescribing Pattern of Antibiotics in Intensive Care Unit of a Tertiary Care Teaching Hospital
Antibiotics are the most commonly administered drugs in ICU. By optimizing the use of antibiotics within ICU, patient outcomes are improved, better initial antibiotics administration is provided, and the chance of furthe...